Pre-market
Loading markets…

Advertisement

Stocks

What's Going On With Diagnos Inc Stock Tuesday?

By Wealth Awesome -

Follow live quotes and coverage.

Stocks & ETFs:ADK.V

Follow ADK

Photos provided by Pexels

Diagnos Inc's stock experiences slight declines amid recent updates.

This week, Diagnos Inc (ADK.V) has seen a decline in its stock price, dropping 2.11% on the day and 3.12% over the week. This performance coincides with updates regarding stock warrants, which have piqued market interest.

Advertisement

Diagnos Inc

ADK.V

Full stock page →

ADK.V

Diagnos Inc

Source:WealthAwesomeWealthAwesome
↑ $0.22 (86.00%)
120 day period
$0.18$0.35$0.51Apr 20Jul 15Oct 9

Market cap

$56.28M

52W high

$0.53

52W low

$0.18

1W change

-3.12%

Beta

0.08

Analyst Price Targets

Based on analyst covering ADK · as of Sep 17, 2026

📈

Wall Street analysts forecast ADK stock price to rise 222.6% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$1.50

+222.6% Upside

Current Price

C$0.47

Last close

Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on ADK's historical volatility

HistoricalForecast68%95%
C$0.18C$0.38C$0.57C$0.76C$0.95C$1.14TodayJun 2Aug 7Oct 9Nov 21Jan 4Feb 16

30-Day Vol

57.7%

Annualized

90-Day Vol

73.0%

Annualized

Trend (90d)

+50.0%

Annualized drift

90d Mean

C$0.56

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$0.49C$0.40 – C$0.60
60 trading daysC$0.52C$0.40 – C$0.69
90 trading daysC$0.56C$0.39 – C$0.78

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Advertisement

Investor takeaway: Despite these recent price declines, the long-term outlook remains positive, with analysts suggesting significant growth potential.

ADK.V's stock is currently at C$0.47.

The stock has a 52-week range of C$0.18 to C$0.53, meaning it is currently trading at 81% of its range, which may indicate potential volatility.

Bull case

Analysts are optimistic, maintaining an average target of C$1.50 for the stock, suggesting a potential upside of over 222% from current levels. The stock has shown a strong upward trend over the past year, indicating growing investor confidence in the healthcare sector.

Bear case

The recent declines in the stock price may reflect market caution, especially considering the company's negative profit margin and return on equity. Additionally, trading volume has been below average, which suggests a decrease in investor interest.

Recent Price Action

Diagnos Inc's stock closed at C$0.47, reflecting a decrease of 2.11% for the day and 3.12% over the past week. However, the company has seen an increase of 8.14% in the last month and a year-to-date rise of 29.17%, indicating a generally positive trend despite the recent pullback.

Company News

Advertisement

On October 6, 2026, Diagnos Inc provided an update regarding stock warrants. While specific details were not mentioned, any news related to warrants can influence investor sentiment and stock performance, which may explain some of the current trading activity.

Technical Picture

From a technical standpoint, Diagnos Inc is trading above its 50-day moving average of C$0.44 by 6.7% and significantly above its 200-day moving average of C$0.31 by 50.1%. The stock has a beta of 0.08, indicating low volatility compared to the broader market. The current trading volume of 175,948 shares is below the 20-day average of 233,504 shares, suggesting reduced activity.

Insider Activity

No insider trading information was provided, so we cannot comment on any recent insider activity.

Price Action Summary

The last close for Diagnos Inc was C$0.47, reflecting a 1D decline of 2.11%. Investors should keep an eye on upcoming developments, especially following the recent warrant update.


Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile →

✅ Reviewed by Certified Financial Professionals

This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

📊 Data AccuracyVerified sources
🇨🇦 Canadian FocusLocal expertise
🔍 Fact-CheckedEditorial review

⚠️ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: October 13, 2026
Last Updated: October 13, 2026

Core portfolio

Awesome Portfolio™

14.8% a year since 2017, against 9.7% for the S&P/TSX Composite. Ten stocks, easy to manage. We update it once a month.

Annualized

+14.8%

Awesome Portfolio™

+9.7%

S&P/TSX

+5.0 pp better a year

Total return

+254%

Awesome Portfolio™

+134%

S&P/TSX

+119 pp better than the TSX

2017-07-31 to 2026-09-29, dividends reinvested, before fees and tax.

Awesome Portfolio™S&P/TSX CompositeCumulative return · 2017-07-31–2026-09-29
-11.7%42.5%96.7%150.9%205.1%259.3%Jul 17Oct 19Feb 22Jun 24Sep 26

Sponsored links

Advertisement